BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 7862142)

  • 21. Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1.
    Gashler AL; Bonthron DT; Madden SL; Rauscher FJ; Collins T; Sukhatme VP
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10984-8. PubMed ID: 1332065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA binding capacity of the WT1 protein is abolished by Denys-Drash syndrome WT1 point mutations.
    Little M; Holmes G; Bickmore W; van Heyningen V; Hastie N; Wainwright B
    Hum Mol Genet; 1995 Mar; 4(3):351-8. PubMed ID: 7795587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNA editing in the Wilms' tumor susceptibility gene, WT1.
    Sharma PM; Bowman M; Madden SL; Rauscher FJ; Sukumar S
    Genes Dev; 1994 Mar; 8(6):720-31. PubMed ID: 7926762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A second transcriptionally active DNA-binding site for the Wilms tumor gene product, WT1.
    Wang ZY; Qiu QQ; Enger KT; Deuel TF
    Proc Natl Acad Sci U S A; 1993 Oct; 90(19):8896-900. PubMed ID: 8415628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The zinc finger transcription factor EGR-1 impedes interleukin-1-inducible tumor growth arrest.
    Sells SF; Muthukumar S; Sukhatme VP; Crist SA; Rangnekar VM
    Mol Cell Biol; 1995 Feb; 15(2):682-92. PubMed ID: 7823937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PAX 8 regulates human WT1 transcription through a novel DNA binding site.
    Fraizer GC; Shimamura R; Zhang X; Saunders GF
    J Biol Chem; 1997 Dec; 272(49):30678-87. PubMed ID: 9388203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequence of the WT1 upstream region including the Wit-1 gene.
    Gessler M; Bruns GA
    Genomics; 1993 Aug; 17(2):499-501. PubMed ID: 8406502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression in Xenopus oocytes shows that WT1 binds transcripts in vivo, with a central role for zinc finger one.
    Ladomery M; Sommerville J; Woolner S; Slight J; Hastie N
    J Cell Sci; 2003 Apr; 116(Pt 8):1539-49. PubMed ID: 12640038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coordinate expression and distinct DNA-binding characteristics of the four EGR-zinc finger proteins in Jurkat T lymphocytes.
    Skerka C; Decker EL; Zipfel PF
    Immunobiology; 1997 Dec; 198(1-3):179-91. PubMed ID: 9442390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repression of the retinoic acid receptor-alpha gene by the Wilms' tumor suppressor gene product, wt1.
    Goodyer P; Dehbi M; Torban E; Bruening W; Pelletier J
    Oncogene; 1995 Mar; 10(6):1125-9. PubMed ID: 7700638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alternative splicing of Wilms' tumor suppressor protein modulates DNA binding activity through isoform-specific DNA-induced conformational changes.
    Laity JH; Chung J; Dyson HJ; Wright PE
    Biochemistry; 2000 May; 39(18):5341-8. PubMed ID: 10820004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Wilms' tumor gene product WT1 activates or suppresses transcription through separate functional domains.
    Wang ZY; Qiu QQ; Deuel TF
    J Biol Chem; 1993 May; 268(13):9172-5. PubMed ID: 8486616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of the DNA-binding and transcriptional repression activity of the Wilms' tumor gene product, WT1, by cAMP-dependent protein kinase-mediated phosphorylation of Ser-365 and Ser-393 in the zinc finger domain.
    Sakamoto Y; Yoshida M; Semba K; Hunter T
    Oncogene; 1997 Oct; 15(17):2001-12. PubMed ID: 9366517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sp1 is a critical regulator of the Wilms' tumor-1 gene.
    Cohen HT; Bossone SA; Zhu G; McDonald GA; Sukhatme VP
    J Biol Chem; 1997 Jan; 272(5):2901-13. PubMed ID: 9006935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of insulin-like growth factor I receptor gene expression by the Wilms' tumor suppressor WT1.
    Werner H; Roberts CT; Rauscher FJ; LeRoith D
    J Mol Neurosci; 1996; 7(2):111-23. PubMed ID: 8873895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Homozygous intragenic deletion in the WT1 gene in a sporadic Wilms' tumour associated with high levels of expression of a truncated transcript.
    Algar EM; Kenney MT; Simms LA; Smith SI; Kida Y; Smith PJ
    Hum Mutat; 1995; 5(3):221-7. PubMed ID: 7599632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repression of the c-myb gene by WT1 protein in T and B cell lines.
    McCann S; Sullivan J; Guerra J; Arcinas M; Boxer LM
    J Biol Chem; 1995 Oct; 270(40):23785-9. PubMed ID: 7559553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Did nucleotides or amino acids drive evolutionary conservation of the WT1 +/-KTS alternative splice?
    Davies RC; Bratt E; Hastie ND
    Hum Mol Genet; 2000 May; 9(8):1177-83. PubMed ID: 10767342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of Wilms tumor 1 transactivation by bone marrow zinc finger 2, a novel transcriptional repressor.
    Lee TH; Lwu S; Kim J; Pelletier J
    J Biol Chem; 2002 Nov; 277(47):44826-37. PubMed ID: 12239212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcription of the dominant-negative helix-loop-helix protein Id1 is regulated by a protein complex containing the immediate-early response gene Egr-1.
    Tournay O; Benezra R
    Mol Cell Biol; 1996 May; 16(5):2418-30. PubMed ID: 8628310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.